821 top medical experts on Tuberculosis across 106 countries and 38 U.S. states, including 674 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Tuberculosis: Any of the infectious diseases of man and other animals caused by species of mycobacterium tuberculosis.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Guideline Central: American Medical Association (1, 2, 3)
- UK NICE Guidelines: Tuberculosis
- PubMed Practice Guideline
- U.S. National Guideline Center (archived)
- Broader Categories (#Experts): Mycobacterium Infections (1,229) and Narrower Categories: Cardiovascular Tuberculosis (391), Central Nervous System Tuberculosis (701), Cutaneous Tuberculosis (1,301), Endocrine Tuberculosis (154), Gastrointestinal Tuberculosis (1,729), Hepatic Tuberculosis (454), Laryngeal Tuberculosis (187), Latent Tuberculosis (2,874), Lymph Node Tuberculosis (3,026), Miliary Tuberculosis (1,476), Multidrug-Resistant Tuberculosis (4,308), Oral Tuberculosis (330), Osteoarticular Tuberculosis (1,914), Pleural Tuberculosis (1,804), Pulmonary Tuberculosis (4,389), Splenic Tuberculosis (186), Tuberculoma (860), Tuberculous Peritonitis (1,045), Urogenital Tuberculosis (390).
- Clinical Trials : at least 1,194 including 50 Active, 667 Completed, 177 Recruiting
- Migliori, Giovanni Battista. Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri - IRCCS - Tradate, Italia.Subjects: Antitubercular Agents; Communicable Disease Control; Disease Eradication; Tuberculosis, Multidrug-Resistant; Global HealthCategories: Epidemiology; Prevention & Control; Drug Therapy; Diagnosis; Therapeutic Use; Therapy
- Dowdy, David W Internal MedicineDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: .Relevant US NIH Grant Funding: $12,755,360 over the last 5 yearsSubjects: Antitubercular Agents; HIV Infections; Isoniazid; Mass Screening; Models, TheoreticalCategories: Diagnosis; Economics; Prevention & Control; Therapeutic Use; Drug Therapy; Epidemiology
- Zumla, Alimuddin IDivision of Infection and Immunity, Centre for Clinical Microbiology, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom.Subjects: Antitubercular Agents; Mycobacterium tuberculosis; HIV Infections; Global Health; Pregnancy Complications, InfectiousCategories: Prevention & Control; Epidemiology; Immunology; Drug Therapy; Diagnosis; Therapeutic Use
- Scriba, Thomas JSouth African Tuberculosis Vaccine Initiative and Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.Relevant US NIH Grant Funding: $2,129,592 over the last 5 yearsSubjects: Mycobacterium tuberculosis; Tuberculosis Vaccines; CD4-Positive T-Lymphocytes; Antigens, Bacterial; HIV InfectionsCategories: Immunology; Prevention & Control; Genetics; Diagnosis; Blood; Therapeutic Use
- Pai, MadhukarMcGill International TB Centre, McGill University, Montreal, Canada.Subjects: Mycobacterium tuberculosis; Interferon-gamma Release Tests; Molecular Diagnostic Techniques; Antitubercular Agents; Global HealthCategories: Diagnosis; Methods; Epidemiology; Prevention & Control; Standards; Economics
- Raviglione, Mario CarloCentre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy.Subjects: Global Health; Communicable Disease Control; Antitubercular Agents; HIV Infections; World Health OrganizationCategories: Prevention & Control; Epidemiology; Drug Therapy; Methods; Therapeutic Use; Organization & Administration
- Singh, Nalini Pediatric Infectious DiseasesChildrens National Health System, George Washington University, Washington, DC, USA.Physician Highly CitedSubjects: Anti-Bacterial Agents; Antitubercular Agents; Databases, Factual; Drug DesignCategories: Drug Therapy; Epidemiology; Microbiology; Pharmacology; Therapeutic Use
- Wilkinson, Robert JohnWellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa.Relevant US NIH Grant Funding: $6,130,467 over the last 5 yearsSubjects: HIV Infections; Mycobacterium tuberculosis; Coinfection; Antitubercular Agents; Immune Reconstitution Inflammatory SyndromeCategories: Immunology; Complications; Drug Therapy; Epidemiology; Genetics; Metabolism
- Alland, David Infectious DiseaseDepartment of Medicine, Rutgers-New Jersey Medical School, Newark, NJ, USA. .Relevant US NIH Grant Funding: $54,801,890 over the last 5 yearsSubjects: Mycobacterium tuberculosis; Antitubercular Agents; Molecular Diagnostic Techniques; Rifampin; Drug Resistance, BacterialCategories: Diagnosis; Methods; Pharmacology; Isolation & Purification; Microbiology; Drug Effects
- Chaisson, Richard E Infectious DiseaseDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. Top HospitalRelevant US NIH Grant Funding: $3,806,262 over the last 5 yearsDisclosed payments from biomedical company (Janssen Research & Development, LLC) in 2021 for $3,720Subjects: HIV Infections; Antitubercular Agents; Isoniazid; AIDS-Related Opportunistic Infections; RifampinCategories: Therapeutic Use; Drug Therapy; Prevention & Control; Administration & Dosage; Complications; Diagnosis
- Hatherill, MarkSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine.Relevant US NIH Grant Funding: $2,575,393 over the last 5 yearsSubjects: Mycobacterium tuberculosis; Tuberculosis Vaccines; BCG Vaccine; CD4-Positive T-Lymphocytes; TranscriptomeCategories: Immunology; Prevention & Control; Diagnosis; Administration & Dosage; Genetics; Methods
- Dheda, KeertanCentre for Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, University of Cape Town, Cape Town, South Africa.Relevant US NIH Grant Funding: $1,334,053 over the last 5 yearsSubjects: Mycobacterium tuberculosis; HIV Infections; Antitubercular Agents; Lipopolysaccharides; SputumCategories: Diagnosis; Methods; Complications; Drug Therapy; Immunology; Urine
- Sterling, Timothy R Infectious DiseaseVanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, TN, USA.Relevant US NIH Grant Funding: $10,125,934 over the last 5 yearsSubjects: HIV Infections; Antitubercular Agents; Mycobacterium tuberculosis; Anti-HIV Agents; AIDS-Related Opportunistic InfectionsCategories: Drug Therapy; Immunology; Complications; Diagnosis; Therapeutic Use; Administration & Dosage
- Walzl, GerhardDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.Relevant US NIH Grant Funding: $6,289,513 over the last 5 yearsSubjects: Mycobacterium tuberculosis; Biomarkers; Antitubercular Agents; Myeloid-Derived Suppressor Cells; HIV InfectionsCategories: Immunology; Diagnosis; Blood; Metabolism; Methods; Therapeutic Use
- Cirillo, Daniela MariaEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.Subjects: Mycobacterium tuberculosis; Antitubercular Agents; Whole Genome Sequencing; Communicable Disease Control; Diagnostic Tests, RoutineCategories: Methods; Diagnosis; Genetics; Epidemiology; Microbiology; Pharmacology
- Murray, Megan B Infectious DiseaseDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America. Top HospitalRelevant US NIH Grant Funding: $34,348,259 over the last 5 yearsSubjects: Mycobacterium tuberculosis; Antitubercular Agents; Diabetes Mellitus; HIV Infections; Diabetes ComplicationsCategories: Epidemiology; Diagnosis; Drug Therapy; Genetics; Microbiology; Immunology
- Nahid, Payam Pulmonary DiseaseUCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America. Top HospitalRelevant US NIH Grant Funding: $23,102,323 over the last 5 yearsSubjects: Antitubercular Agents; Mycobacterium tuberculosis; Clinical Trials as Topic; Isoniazid; Research DesignCategories: Methods; Drug Therapy; Therapeutic Use; Immunology; Epidemiology; Diagnosis
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.